ATLANTA, Oct. 12 /PRNewswire-FirstCall/ -- NDCHealth Corporation
(NYSE:NDC), a leading provider of healthcare technology and
information solutions, today announced financial and operating
results for its fiscal first quarter ended September 2, 2005. Total
revenue from continuing operations was $100.0 million, a 9.9%
increase from $91.0 million in the first quarter of fiscal 2005.
Income from continuing operations for the first quarter was $2.6
million, or $0.07 per diluted share, compared to income of $0.8
million, or $0.02 per diluted share, in the same period in fiscal
2005. Net income after discontinued operations for the first
quarter of fiscal 2006 was $2.6 million, or $0.07 per diluted
share, compared to a net loss of $7.0 million, or ($0.19) per
diluted share, in the first quarter of fiscal 2005. Adjusted income
from continuing operations(1), a non-GAAP measure, for the first
quarter of fiscal 2006 was $0.15 per diluted share, compared to
adjusted income from continuing operations in the first quarter of
fiscal 2005 of $0.03 per diluted share. Adjusted EBITDA(2), also a
non-GAAP measure, in the first quarter increased 37.4% to $25.1
million, versus $18.2 million in the same period of fiscal 2005.
Adjusted income and adjusted EBITDA exclude the effect of
Restructuring, Special Governance and Other Charges, which in the
first quarter consisted of $3.9 million in expenses associated with
the pending sale of the company and costs associated with
stockholder litigation and the SEC investigation. The first quarter
of fiscal 2006 included the impact of one additional week of
operating results when compared to the comparable quarter in fiscal
2005. The incremental 14th week added approximately $2.4 million in
revenue and $2.6 million in total expenses. "Our first quarter
results illustrate our ability to deliver growth and increased
profitability as we continue to see momentum across all of our
businesses," said Walter Hoff, NDCHealth chairman and chief
executive officer. "This performance demonstrates that our efforts
to more tightly focus our business activities, implement improved
operating practices and increase our market penetration through
product enhancements and new introductions have been successful. We
continue to believe our operational activities point to clear signs
that these businesses can achieve long-term, sustainable growth in
revenue and earnings." First Quarter Financial Review NDCHealth
reports its financial and operating performance in four segments:
Pharmacy Services and Systems, Hospital Solutions, Physician
Solutions and Information Management. On a business segment basis:
- Pharmacy Services and Systems revenue increased $2.4 million, or
7.6%, in the first quarter of fiscal 2006 compared to the same
quarter of fiscal 2005, reflecting an increase in pharmacy
transaction services revenue as well as higher revenue from system
sales to independent and mail order pharmacies, partially offset by
a decline in legacy systems revenue. The incremental 14th week in
the quarter added approximately $1.2 million in transaction
services revenue and $0.6 million in operating expense. Segment
operating margin was 17.5% versus 10.1% in the same quarter a year
ago. - Hospital Solutions revenue in the first quarter of fiscal
2006 increased $1.5 million, or 9.0%, from the first quarter last
fiscal year, driven by increased sales and installations of NDC
ePREMIS(R) at higher per transaction pricing than the legacy PREMIS
system. The incremental 14th week in the quarter added
approximately $0.8 million in transaction services revenue and $0.2
million in operating expense. Segment operating margin was 30.9%
versus 26.5% in the same quarter a year ago. - Physician Solutions
revenue increased $1.1 million, or 17.3%, in the first quarter of
fiscal 2006 compared to the same period in fiscal 2005 due to
higher system sales. The incremental 14th week in the quarter added
approximately $0.4 million in additional revenue and $0.2 million
in operating expense. Segment operating margin was 24.7% versus
8.6% in the same quarter a year ago. - Information Management
revenue in the first quarter increased $4.0 million, or 10.9%,
compared to the same quarter in fiscal 2005, driven by growth in
core product and service offerings as well as new product growth
from the company's advanced analysis, market research and
longitudinal product solutions. The additional 14th week in the
quarter had an immaterial effect on revenue but added approximately
$0.8 million in operating expense. Segment operating margin was
5.8% versus a breakeven operating margin in the same quarter a year
ago. On a consolidated basis: - Cost of Service in the first
quarter increased $0.8 million, or 1.5%, from the same quarter of
fiscal 2005 due primarily to the impact of additional compensation
expense in the 14th accounting week, which offset cost savings from
lower staffing levels and data costs when compared to the first
quarter last year. - Sales, General and Administrative expense in
the first quarter of fiscal 2006 increased $1.4 million, or 6.2%,
from the same period a year ago. The incremental 14th week added
about $1.0 million in Sales, General and Administrative expense in
the quarter. - Restructuring, Special Governance and Other Charges
in the quarter increased $3.5 million from the first quarter of
fiscal 2005, reflecting expenses associated with the pending sale
of the company and costs associated with stockholder litigation and
the SEC investigation. - Total outstanding debt at September 2,
2005 was $254.7 million, down $16.1 million from $270.8 million at
May 27, 2005. Business Highlights - Pharmacy network services
volume totaled more than 1.63 billion transactions in the first
quarter of fiscal 2006, a 25.7% increase from the same period last
year as NDCHealth benefited from an incremental 14th week as well
as continuing to increase penetration of its core claims processing
and pre- and post-edit transaction services. - The company has now
signed agreements for seven pharmacy chains to implement the NDC
EnterpriseRx(TM) pharmacy management system, a robust inventory,
central fill and centralized patient management solution. Initial
installations and revenue are expected to begin in the third
quarter of fiscal 2006, which will also positively affect cash
flow. - NDCHealth sold an additional 41 ePREMIS units and installed
109 units during the first quarter of fiscal 2006, increasing the
total ePREMIS installed base to 665 sites. New ePREMIS sales are
expected to increase in the second quarter from the seasonally
slower activity experienced during the summer months. - On
September 29th, the company announced a long-term agreement whereby
Acxiom Corporation will transform and manage the technology
infrastructure of NDCHealth's Information Management business unit.
The collaborative project will create a proprietary data factory
utilizing Acxiom's automated grid-enabled information management
platform that is expected to allow the Information Management unit
to develop and deploy new information product offerings faster and
at a lower cost. - NDCHealth recently announced it received
notification of early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect
to the proposed sale of its Information Management business to
Wolters Kluwer and the proposed merger of NDCHealth with Per-Se
Technologies. As disclosed on August 29, 2005, the companies signed
definitive agreements pertaining to these transactions, which,
subject to approval by both NDCHealth and Per-Se stockholders and
other customary closing conditions, are anticipated to close in
NDCHealth's fiscal third quarter. Financial Outlook For the second
quarter of fiscal 2006 ending December 2, 2005, management expects
revenue to be in the range of $98.5 million to $101.0 million.
Adjusted EBITDA(2) is expected to be in the range of $24.5 million
to $27.0 million, before approximately $2.5 million in estimated
Restructuring, Special Governance and Other Charges. Adjusted
income per diluted share from continuing operations(1), before
Restructuring, Special Governance and Other Charges, is expected to
be in the range of $0.13 to $0.17 in the second quarter of fiscal
2006, versus $0.06 in adjusted income per diluted share in the same
period of fiscal 2005. Conference Call and Webcast NDCHealth will
host a conference call to discuss its financial results and
business outlook beginning at 5:00 pm ET today, October 12, 2005.
To listen to the conference call, please dial 877-421-3895
(706-679-0822 for international callers), or access the webcast
through the Investor Relations page at http://www.ndchealth.com/. A
replay of the conference call will be available via webcast or by
dialing 800-642-1687 (706-645-9291 for international callers) and
entering conference ID 1205542. Cautionary Information Regarding
Forward-Looking Statements This press release contains
forward-looking statements, including those related to the
company's financial guidance for the second quarter of fiscal 2006.
These statements involve risks and uncertainties that may cause
actual results to differ materially. NDCHealth's projected results
for future periods are based on preliminary estimates, assumptions
and projections that management believes to be reasonable at this
time, but may be beyond management's control. Forward-looking
statements are only predictions and are not guarantees of
performance, and include statements preceded by, followed by or
that include the words "may," "could," "would," "should,"
"believe," "expect," "anticipate," "plan," "estimate," "target,"
"project," "intend," or similar expressions. These statements
include, among others, statements regarding the company's expected
business outlook, anticipated financial and operating results, its
business strategy and means to implement the strategy, the
company's objectives, the likelihood of the company's success in
developing and introducing new products and expanding its business,
the timing of the introduction of new and modified products or
services, and sources of liquidity. These forward-looking
statements are based on management's beliefs and assumptions, which
in turn are based on currently available information. Important
risks and assumptions relating to the forward-looking statements
include, without limitation: (1) the completion of the announced
sale of the company; (2) the ability to retain employees despite
uncertainty created by the pending sale of the company; (3) the
company's ability to comply with the Sarbanes-Oxley Act of 2002;
(4) demand for the company's products and services; (5) the
company's ability to expand in new and existing markets; (6) the
cost of product development; (7) the timely completion, market
demand and acceptance of the company's products; (8) competitive
forces; (9) industry conditions affecting NDCHealth's customers;
(10) expected pricing levels; (11) expected growth of revenue and
net income; (12) access to data from suppliers; (13) complex state
and federal regulations and their impact on the demand for
information products or availability of certain data; (14) the
timing and cost of planned capital expenditures; (15) the
availability of capital to invest in business growth and expansion;
(16) the timing of recognition of certain revenue; (17) the
potential for information or network services interruptions; (18)
adequate protection of proprietary technology; (19) unanticipated
changes in accounting rules and/or interpretations; (20) outcomes
and cost of litigation and/or the Securities and Exchange
Commission investigation; (21) the company's ability to maintain
compliance with certain restrictive debt covenants; and (22) the
company's substantial indebtedness, which could adversely affect
its financial condition, results of operations and liquidity. Many
of these risk factors and assumptions are beyond the company's
ability to control or predict, and are not intended to represent a
complete list of all risks and uncertainties inherent in the
company's business, and should be read in conjunction with the more
detailed cautionary statements included in NDCHealth's Annual
Report on Form 10-K/A for the fiscal year ended May 27, 2005 and
other company filings with the Securities and Exchange Commission.
The company believes its forward-looking statements are reasonable;
however, undue reliance should not be placed on any forward-looking
statements, which are based on the company's current assumptions
and expectations. Forward- looking statements speak only as of the
date they are made, and the company undertakes no obligation to
update publicly any of them in light of new information or future
events. Important Legal Information This communication shall not
constitute an offer of any securities for sale. In connection with
the proposed merger of NDCHealth Corporation with Per-Se
Technologies, Inc., NDCHealth and Per-Se have filed a registration
statement on Form S-4 containing a preliminary joint proxy
statement/prospectus for the stockholders of both companies with
the SEC, and each will file other documents regarding the proposed
transactions with the SEC as well. The final joint proxy
statement/prospectus will be mailed to the stockholders of both
NDCHealth and Per-Se, and investors are urged to carefully read the
final document, as well as any amendments and supplements thereto,
and any other relevant documents in their entirety before making
any voting or investment decision as they will contain important
information about the proposed transaction. You may obtain copies
of all documents filed with the SEC regarding this transaction,
free of charge, at the SEC's website (http://www.sec.gov/). You may
also obtain these documents, free of charge, from NDCHealth's
website (http://www.ndchealth.com/) under the tab "Investor
Relations" through the "SEC Filing" link. You may also obtain these
documents, free of charge, from Per-Se's website
(http://www.per-se.com/) under the tab "Investors" through the "SEC
Filing" link. NDCHealth Corporation and Per-Se Technologies and
their respective directors and executive officers may be deemed
participants in the solicitation of proxies from stockholders in
connection with this transaction. Information about the directors
and executive officers of NDCHealth and Per-Se Technologies and
information about other persons who may be deemed participants in
this transaction will be included in the joint proxy
statement/prospectus. You can find information about NDCHealth's
executive officers and directors in NDCHealth's Form 10-K/A filed
with the SEC on September 14, 2005. You can find information about
Per-Se Technologies' executive officers and directors in Per-Se's
definitive proxy statement filed with the SEC on March 25, 2005.
About NDCHealth NDCHealth is a leading information solutions
company serving all sectors of healthcare. Its network solutions
automate the exchange of information among pharmacies, payers,
hospitals and physicians. Its systems and information management
solutions help improve operational efficiencies and business
decision making for providers, retail pharmacy and pharmaceutical
manufacturers. Headquartered at Atlanta, Ga., NDCHealth provides
information vital to the delivery of healthcare every day. For
additional information, please visit http://www.ndchealth.com/.
NDCHealth is a trademark of NDCHealth Corporation. All other
company and product names mentioned may be trademarks of the
company. (1) Adjusted income per share from continuing operations,
a non-GAAP measure, can be derived from the company's Condensed
Consolidated Statements of Operations, and is defined as Income
from Continuing Operations, before the after-tax effect of
Restructuring, Special Governance and Other Charges, on a per share
basis. Reconciliation of adjusted income from continuing operations
to Income from Continuing Operations, the most directly comparable
GAAP financial measure, is provided in an accompanying table. (2)
Adjusted EBITDA, a non-GAAP measure, can be derived from the
company's Condensed Consolidated Statements of Operations, and is
defined as Operating Income before Depreciation and Amortization,
and Restructuring, Special Governance and Other Charges.
Reconciliation of adjusted EBITDA to Operating Income, the most
directly comparable GAAP financial measure, is provided in an
accompanying table. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
NDCHealth Corporation and Subsidiaries (Unaudited) (In thousands,
except per share data) Three Months Ended September 2, August 27,
2005 2004 Revenue $99,980 $91,008 Operating Expenses: Cost of
Service 51,201 50,434 Sales, General and Administrative 23,708
22,333 Depreciation and Amortization 9,493 10,269 Restructuring,
Special Governance and Other Charges 3,926 388 88,328 83,424
Operating Income 11,652 7,584 Other Income (Expense): Interest and
Other Income 154 61 Interest and Other Expense (7,046) (6,395)
(6,892) (6,334) Income from Continuing Operations before Income
Taxes 4,760 1,250 Provision for Income Taxes 2,121 488 Income from
Continuing Operations 2,639 762 Loss from Discontinued Operations -
(7,727) Net Income (Loss) $2,639 $(6,965) Basic Earnings (Loss) Per
Share: Income from Continuing Operations $0.07 $0.02 Discontinued
Operations $- $(0.22) Basic Earnings (Loss) Per Share $0.07 $(0.20)
Weighted Average Shares 35,955 35,638 Diluted Earnings (Loss) Per
Share: Income from Continuing Operations $0.07 $0.02 Discontinued
Operations $- $(0.21) Diluted Earnings (Loss) Per Share $0.07
$(0.19) Weighted Average Shares 36,191 36,002 CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS NDCHealth Corporation and
Subsidiaries (Unaudited) (In thousands) Three Months Ended
September 2, August 27, 2005 2004 Cash flows from operating
activities: Net income (loss) $2,639 $(6,965) Adjustments to
reconcile net income (loss) to cash provided by (used in) operating
activities: Loss on discontinued operations - 7,727 Depreciation
and amortization 9,493 10,269 Deferred income taxes 2,121 529
Allowance for doubtful accounts 1,547 1,960 Other, net 1,459 1,186
Total 17,259 14,706 Changes in assets and liabilities: Accounts
receivable, net 1,431 (640) Prepaid expenses and other assets 7,183
4,597 Accounts payable and accrued liabilities (10,820) (15,291)
Accrued interest on long-term debt (4,893) (5,379) Deferred revenue
(737) (5,281) Total (7,836) (21,994) Net cash provided by (used in)
operating activities 9,423 (7,288) Cash flows from investing
activities: Capital expenditures-Property Acquisitions (3,449)
(6,677) Capital expenditures-Capitalized External Use Software
(4,642) (4,005) Acquisitions and other investing activities (11)
(1,838) Net cash used in investing activities (8,102) (12,520) Cash
flows from financing activities: Net repayments/borrowings under
lines of credit (5,000) 38,500 Principal payments under long-term
debt arrangements (11,081) (29,446) Net issuances related to stock
activities 345 (71) Dividends paid - (1,439) Net cash (used in)
provided by financing activities (15,736) 7,544 Cash provided by
divestiture of discontinued operations 11,609 - Net cash used in
discontinued operations (715) (7,904) Decrease in cash and cash
equivalents (3,521) (20,168) Cash and cash equivalents, beginning
of period 17,790 24,585 Cash and cash equivalents, end of period
$14,269 $4,417 CONDENSED CONSOLIDATED BALANCE SHEETS NDCHealth
Corporation and Subsidiaries (Unaudited) (In thousands, except
share data) September 2, May 27, 2005 2005 ASSETS Current Assets:
Cash and Cash Equivalents $14,269 $17,790 Accounts Receivable (Less
Allowance of $7,539 and $6,603 respectively.) 48,027 50,977 Prepaid
Expenses 18,495 22,777 Deferred Income Taxes 4,424 6,214 Other
Current Assets 9,352 8,843 Total Assets of Discontinued Operations
- 36,245 Total Current Assets 94,567 142,846 Property and
Equipment, Net 66,619 69,842 Capitalized External Use Software, Net
72,481 68,474 Goodwill 352,064 351,474 Intangible Assets, Net
59,418 61,886 Debt Issuance Cost 10,842 11,496 Deferred Income
Taxes 18,019 18,350 Other Assets 23,754 25,299 Total Assets
$697,764 $749,667 LIABILITIES AND STOCKHOLDERS' EQUITY Current
Liabilities: Current Portion of Long-term Debt $25,939 $31,529
Trade Accounts Payable 21,102 24,033 Accrued Compensation and
Benefits 7,051 9,901 Accrued Interest 5,631 10,524 Deferred Revenue
33,655 34,772 Other Accrued Liabilities 30,983 33,795 Total
Liabilities of Discontinued Operations - 11,967 Total Current
Liabilities 124,361 156,521 Deferred Revenue 4,005 4,602 Other
Non-current Liabilities 25,563 26,789 Long-term Debt 228,764
239,255 Total Liabilities 382,693 427,167 Commitments and
Contingencies - - Stockholders' Equity: Preferred Stock, par value
$1.00 per share; 1,000,000 shares authorized, none issued - -
Common Stock, par value $.125 per share; 200,000,000 shares
authorized; 36,206,400 and 36,210,808 shares issued, respectively.
4,526 4,526 Capital in excess of par value 248,728 248,446 Retained
Earnings 73,546 70,907 Deferred Compensation and Other (4,498)
(5,039) Other Comprehensive (Loss) Income (7,231) 3,660 Total
Stockholders' Equity 315,071 322,500 Total Liabilities and
Stockholders' Equity $697,764 $749,667 ADJUSTED INCOME PER SHARE
FROM CONTINUING OPERATIONS RECONCILIATION NDCHealth Corporation and
Subsidiaries (Continuing Operations) Adjusted Diluted Income Per
Share from Continuing Operations is defined as Income from
Continuing Operations before the after-tax effect of Restructuring,
Special Governance and Other Charges on a per share basis. Adjusted
Diluted Income Per Share is not a Generally Accepted Accounting
Principles (GAAP) measurement and may not be comparable to Earnings
Per Share reported by other companies. Management believes Adjusted
Diluted Income Per Share is useful to investors, analysts and
others because it provides a meaningful representation of the
company's ongoing operating earnings performance as it excludes
certain items that management believes are not reflective of the
company's core operating results over time. Reconciliation of
Adjusted Income Per Share from Continuing Operations to Diluted
Earnings Per Share from Continuing Operations, the most directly
comparable GAAP financial measure, for the three-month ended
September 2, 2005 and August 27, 2004 is provided below. Non-GAAP
measures should be evaluated in conjunction with, and are not a
substitute for, GAAP financial measures. Three Months Ended
September 2, August 27, 2005 2004 Income from Continuing Operations
(After-tax) $2,639 $762 (Effective Tax Rates: 44.6%* in Q1 FY06 and
39.0% in Q1 FY05) Restructuring, Special Governance and Other
Charges (After-tax) $2,736 $237 (Effective Tax Rates: 30.3% in Q1
FY06 and 39.0% in Q1 FY05) Adjusted Income from Continuing
Operations $5,375 $999 Weighted Average Shares - Diluted 36,191
36,002 Three Months Ended September 2, August 27, 2005 2004 Diluted
Income Per Share from Continuing Operations $0.07 $0.02
Restructuring, Special Governance and Other Charges $0.08 $0.01
Adjusted Income Per Share from Continuing Operations $0.15 $0.03 *
The effective tax rate of 44.6% in the first quarter of fiscal 2006
reflects the effect of certain non-deductible expenses included in
Restructuring, Special Governance and Other Charges in the quarter,
and is not expected to be representative of the tax rate for the
remainder of fiscal 2006. ADJUSTED EBITDA RECONCILIATION NDCHealth
Corporation and Subsidiaries Adjusted EBITDA is defined as
Operating Income before Depreciation and Amortization, and
Restructuring, Special Governance and Other Charges. Adjusted
EBITDA is not a Generally Accepted Accounting Principles (GAAP)
measurement and may not be comparable to EBITDA reported by other
companies. Management believes Adjusted EBITDA is useful to
investors, analysts and others because it provides a more
meaningful representation of the company's performance as it
excludes certain items that either do not impact the company's cash
flows or which management believes are not reflective of the
company's core operating results over time. Reconciliation of
Adjusted EBITDA to Operating Income, the most directly comparable
GAAP financial measure, for the three-month periods ended September
2, 2005 and August 27, 2004 is provided below. Non-GAAP measures
should be evaluated in conjunction with, and are not a substitute
for, GAAP financial measures. (In Thousands) Three Months Ended
September 2, August 27, 2005 2004 Operating Income $11,652 $7,584
Depreciation and Amortization 9,493 10,269 Restructuring, Special
Governance and Other Charges 3,926 388 Adjusted EBITDA $25,071
$18,241 SEGMENT FINANCIAL SUMMARY NDCHealth Corporation and
Subsidiaries (Continuing Operations) (In Thousands) Q1/Q1 FY 2005
FY 2006 Y-Y Qtr 1 Qtr 2 Qtr 3 Qtr 4 Qtr 1 % Change Pharmacy
Services and Systems: Revenue $31,154 $32,717 $33,143 $31,650
$33,510 7.6% Operating Income before Charges $3,159 $2,364 $4,916
$4,878 $5,868 85.8% % margin 10.1% 7.2% 14.8% 15.4% 17.5%
Restructuring, Special Governance and Other Charges $- $- $(1,162)
$(4,910) $- Operating Income after Charges $3,159 $2,364 $3,754
$(32) $5,868 85.8% Hospital Solutions: Revenue $16,144 $15,535
$15,730 $16,856 $17,596 9.0% Operating Income before Charges $4,279
$3,336 $3,876 $4,798 $5,445 27.2% % margin 26.5% 21.5% 24.6% 28.5%
30.9% Restructuring, Special Governance and Other Charges $- $(265)
$(501) $(115) $- Operating Income after Charges $4,279 $3,071
$3,375 $4,683 $5,445 27.2% Physician Solutions: Revenue $6,477
$7,943 $10,610 $7,480 $7,599 17.3% Operating Income before Charges
$556 $1,522 $3,964 $2,096 $1,879 237.9% % margin 8.6% 19.2% 37.4%
28.0% 24.7% Restructuring, Special Governance and Other Charges
(Benefit) $- $(646) $(45) $(23) $- Operating Income after Charges
$556 $876 $3,919 $2,073 $1,879 237.9% Information Management:
Revenue $37,233 $40,485 $40,632 $43,769 $41,275 10.9% Operating
Income before Charges $(22) $2,635 $3,397 $2,633 $2,386 nm % margin
-0.1% 6.5% 8.4% 6.0% 5.8% Restructuring, Special Governance and
Other Charges $- $(433) $(140) $- $- Operating Income after Charges
$(22) $2,202 $3,257 $2,633 $2,386 nm Other: (1) Operating Expense
$(388) $(1,535) $(1,222) $(3,592) $(3,926) nm NDCHealth - Total
Revenue $91,008 $96,680 $100,115 $99,755 $99,980 9.9% Operating
Income before Charges $7,972 $9,857 $16,153 $14,405 $15,578 95.4% %
margin 8.8% 10.2% 16.1% 14.4% 15.6% Restructuring, Special
Governance and Other Charges $(388) $(2,879) $(3,070) $(8,640)
$(3,926) nm Operating Income after Charges $7,584 $6,978 $13,083
$5,765 $11,652 53.6% 8.3% 7.2% 13.1% 5.8% 11.7% (1) Includes
Restructuring, Special Governance and Other Charges not directly
identified to an Operating Segment. DATASOURCE: NDCHealth
Corporation CONTACT: Robert Borchert, VP-Investor Relations of
NDCHealth Corporation, +1-404-728-2906, or Web site:
http://www.ndchealth.com/
Copyright
Ndchealth (NYSE:NDC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Ndchealth (NYSE:NDC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024